M. Aschner et al., METHYLMERCURY-INDUCED INHIBITION OF REGULATORY VOLUME DECREASE IN ASTROCYTES - CHARACTERIZATION OF OSMOREGULATOR EFFLUX AND ITS REVERSAL BYAMILORIDE, Brain research, 811(1-2), 1998, pp. 133-142
Swelling of neonatal rat primary astrocyte cultures by hypotonic media
leads to regulatory volume decrease (RVD) and the resumption of resti
ng cell volume. RVD is associated with activation of conductive K+ and
Cl- channels, allowing for the escape of KCl, as well as the release
of osmoregulators, such as taurine and myoinositol. As we have previou
sly shown [D. Vitarella, H.K. Kimelberg, M. Aschner, Inhibition of RVD
in swollen rat primary astrocyte cultures by methylmercury (MeHg) is
due to increase amiloride-sensitive Na+ uptake, Brain Res. 732 (1996)
169-178.], MeHg, when added to hypotonic buffer inhibits RVD, primaril
y due to increased cellular permeability to Na+ via the Na+/H+ antipor
ter. The present study was, therefore, undertaken to assess the abilit
y of cation-anion cotransport blockers to reverse the inhibitory effec
t of MeHg on RVD in swollen astrocytes, and to further characterize Me
Hg-induced changes in astrocytic osmoregulatory release processes. The
studies demonstrate the following: (1) MeHg-induced inhibition of RVD
is partially inhibited by the Na+/H+ antiporter blocker, amiloride, b
ut not SITS acetamido-4'-isothiocyanatostilbene-2,2'disulfonic acid),
DIDS (4,4'-diisothiocyano-2,2'-stilbenedisulfonic acid), furosemide or
bumetanide; (2) exposure of swollen astrocytes to MeHg is associated
with specific effects on osmoregulatory release, leading to significan
t inhibition of taurine release and a significant increase in potassiu
m and myoinositol release compared with release in hypotonic condition
s. (C) 1998 Elsevier Science B.V. All rights reserved.